注射依诺肝素。 - Suppr

Suppr

超能文献

Administering an enoxaparin injection.

作者信息

Rushing Jill

机构信息

University of Southern Mississippi in Hattiesburg, USA.

出版信息

Nursing. 2008 Mar;38(3):19. doi: 10.1097/01.NURSE.0000312604.60149.84.

DOI:10.1097/01.NURSE.0000312604.60149.84

PMID:18418159

Abstract

摘要

相似文献

Administering an enoxaparin injection.

Nursing. 2008 Mar;38(3):19. doi: 10.1097/01.NURSE.0000312604.60149.84.

A study on the effect of the duration of subcutaneous heparin injection on bruising and pain.

J Clin Nurs. 2008 Feb;17(3):378-85. doi: 10.1111/j.1365-2702.2006.01933.x. Epub 2007 Oct 11.

An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers.

Clin Appl Thromb Hemost. 2011 Feb;17(1):66-9. doi: 10.1177/1076029610393332.

Regarding "Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients".

J Vasc Surg. 2003 Mar;37(3):700-1; author reply 701. doi: 10.1067/mva.2003.134.

Administering subcutaneous heparin.

Nursing. 2000 Jun;30(6):17. doi: 10.1097/00152193-200030060-00004.

FDA approves generic enoxaparin.

JAMA. 2010 Aug 25;304(8):844. doi: 10.1001/jama.2010.1195.

An unexpected complication of DVT prophylaxis.

Acta Orthop Belg. 1997 Jun;63(2):134-5.

Patch-test positivity in cutaneous reactions to enoxaparin.

Contact Dermatitis. 2000 Jan;42(1):43.

Eczema-like plaques secondary to enoxaparin.

Contact Dermatitis. 2006 Jan;54(1):18-20. doi: 10.1111/j.0105-1873.2006.00711.x.

A bioavailability study in the proposed patient population--with much more needed now.

Crit Care Med. 2003 May;31(5):1588-9. doi: 10.1097/01.CCM.0000059726.55857.C5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Administering an enoxaparin injection.

Nursing. 2008 Mar;38(3):19. doi: 10.1097/01.NURSE.0000312604.60149.84.

A study on the effect of the duration of subcutaneous heparin injection on bruising and pain.

J Clin Nurs. 2008 Feb;17(3):378-85. doi: 10.1111/j.1365-2702.2006.01933.x. Epub 2007 Oct 11.

An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers.

Clin Appl Thromb Hemost. 2011 Feb;17(1):66-9. doi: 10.1177/1076029610393332.

Regarding "Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients".

J Vasc Surg. 2003 Mar;37(3):700-1; author reply 701. doi: 10.1067/mva.2003.134.

Administering subcutaneous heparin.

Nursing. 2000 Jun;30(6):17. doi: 10.1097/00152193-200030060-00004.

FDA approves generic enoxaparin.

JAMA. 2010 Aug 25;304(8):844. doi: 10.1001/jama.2010.1195.

An unexpected complication of DVT prophylaxis.

Acta Orthop Belg. 1997 Jun;63(2):134-5.

Patch-test positivity in cutaneous reactions to enoxaparin.

Contact Dermatitis. 2000 Jan;42(1):43.

Eczema-like plaques secondary to enoxaparin.

Contact Dermatitis. 2006 Jan;54(1):18-20. doi: 10.1111/j.0105-1873.2006.00711.x.

A bioavailability study in the proposed patient population--with much more needed now.

Crit Care Med. 2003 May;31(5):1588-9. doi: 10.1097/01.CCM.0000059726.55857.C5.